Related Experiment Video
Updated: Jul 5, 2025

07:51
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
3.3K
A Portable and Disposable Electrochemical Sensor Utilizing Laser-Scribed Graphene for Rapid SARS-CoV-2 Detection
Runzhong Wang1, Bicheng Zhu1,2,3, Paul Young4,5
1Centre for Innovative Materials and Health, School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Biosensors
|January 22, 2024
Summary
This study presents a novel electrochemical biosensor for rapid COVID-19 detection. The laser-scribed graphene sensor utilizes a unique ligase system for high-sensitivity detection of the SARS-CoV-2 spike protein.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Analytical Chemistry
Background:
- The COVID-19 pandemic necessitated rapid and accurate diagnostic tools.
- Quantitative reverse transcription polymerase chain reaction (RT-qPCR) is sensitive but time-consuming.
- Rapid antigen tests (RATs) offer speed but suffer from lower sensitivity and false negatives.
Purpose of the Study:
- To develop a disposable, electrochemical biosensor for sensitive and specific detection of SARS-CoV-2.
- To utilize a laser-scribed graphene (LSG) platform with a novel immobilization strategy.
- To improve upon the limitations of existing COVID-19 diagnostic methods.
Main Methods:
- Development of LSG-based biosensor strips.
- Employing a split-ester bond ligase system (EsterLigase) for nanobody immobilization.
- Using an anti-spike VHH E nanobody as the probe for the spike receptor-binding domain (SP-RBD).
- Measuring target recognition via electrochemical impedance spectroscopy (EIS).
Main Results:
- Achieved a linear detection range for SP-RBD from 150 pM to 15 nM.
- Demonstrated a sensitivity of 0.0866 [log(M)]-1.
- Obtained a limit of detection (LOD) of 7.68 pM.
Conclusions:
- The developed LSG-based biosensor offers a promising approach for sensitive COVID-19 detection.
- The EsterLigase system facilitates effective nanobody orientation for enhanced probe-target recognition.
- This technology has the potential for rapid, point-of-care diagnostics.

